Submit Deal

Nick Galakatos

Global Head of Life Sciences at BLACKSTONE LIFE SCIENCES

Investor

Deal Bio

Total Deals7

Valued Deals5

Total Value£ 5.34 B

Avg. Deal Size£ 1.07 B

Market Context

Sort

04 Oct 2018|United States|Venture Capital

Target: CLARUS VENTURES LLC

Bidder: BLACKSTONE GROUP INC

3 Service Providers

1 Target | 2 Bidder

4 Dealmakers

1 Target | 3 Bidder

n/a

Value

27 Feb 2019|United States|Biotechnology

Target: ANTHOS THERAPEUTICS

Bidder: BLACKSTONE GROUP INC

3 Service Providers

1 Target | 2 Bidder

6 Dealmakers

2 Target | 4 Bidder

n/a

Value

25 Nov 2019|Switzerland|Pharmaceuticals

Target: FERGENE

Bidder: FERRING PHARMACEUTICALS

2 Service Providers

2 Bidder

5 Dealmakers

5 Bidder

£ 443 M

Value

13 Apr 2020|United States|Pharmaceuticals

Target: ALNYLAM

Bidder: BLACKSTONE GROUP INC

7 Service Providers

3 Target | 4 Bidder

53 Dealmakers

23 Target | 31 Bidder

£ 1.60 B

Value

12 Jun 2020|Ireland|Medical Supplies

Target: MEDTRONIC PLC

Bidder: BLACKSTONE GROUP INC

4 Service Providers

2 Target | 2 Bidder

20 Dealmakers

7 Target | 13 Bidder

£ 266 M

Value

11 Feb 2025|United States|Biotechnology

Target: ANTHOS THERAPEUTICS

Bidder: NOVARTIS AG

9 Service Providers

5 Target | 2 Bidder | 2 Vendor

30 Dealmakers

8 Target | 10 Bidder | 12 Vendor

£ 2.50 B

Value

04 Nov 2025|Canada|Pharmaceuticals

Target: MERCK & CO INC

Bidder: BLACKSTONE LIFE SCIENCES

3 Service Providers

2 Target | 1 Bidder

8 Dealmakers

7 Target | 1 Bidder

£ 523 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy